Role of NF-kappaB and PPAR-gamma in lung inflammation induced by monocyte-derived microparticles

T Neri1, C Armani, A Pegoli

  • 1Dipartimento Cardiotoracico e Vascolare, Laboratory of Respiratory Cell Biology, University of Pisa, Via Paradisa, 2 56124 Pisa, Italy.

Insights

Monocyte-derived microparticles (MP) induce lung inflammation via NF-κB activation. Peroxisome proliferator-activated receptor gamma (PPAR-γ) agonists inhibit this inflammatory response, revealing a PPAR-γ dependent pathway.

Area of Science:

  • Cell Biology
  • Immunology
  • Molecular Biology

Background:

  • Microparticles (MP) are vesicles shed by activated or apoptotic cells.
  • Monocyte-derived MP are known to increase pro-inflammatory mediators in lung epithelial cells.
  • The underlying molecular mechanisms for this effect are not fully understood.

Purpose of the Study:

  • To investigate if NF-κB activation mediates the upregulation of pro-inflammatory cytokines by monocyte-derived MP in lung epithelial cells.
  • To determine if Peroxisome proliferator-activated receptors gamma (PPAR-γ) modulate this inflammatory response.

Main Methods:

  • Human monocytes/macrophages were stimulated to generate MP.
  • MP were incubated with human lung epithelial cells (A549 alveolar and bronchial cells).
  • NF-κB translocation, Interleukin-8 (IL-8), and Monocyte Chemotactic Protein-1 (MCP-1) synthesis were assessed using electrophoretic mobility shift assay, ELISA, and RT-PCR.

Main Results:

  • Monocyte/macrophage-derived MP increased NF-κB activation and IL-8/MCP-1 synthesis in lung epithelial cells.
  • Pre-incubation with PPAR-γ agonists (rosiglitazone, 15-deoxy-Δ12,14-prostaglandin-J2) inhibited MP-induced inflammation.
  • The inhibitory effects of PPAR-γ agonists were reversed by the antagonist GW9662.

Conclusions:

  • Upregulation of pro-inflammatory mediators by monocyte/macrophage-derived MP in lung epithelial cells is mediated by NF-κB activation.
  • This process is dependent on a Peroxisome proliferator-activated receptor gamma (PPAR-γ) pathway.